SOUTH KOREA · OPENDART
SEOUL PHARMA CO.,LTD
서울제약 · 018680 · KOSDAQ · Healthcare · Drug Manufacturers—Specialty & Generic
Score
Not ranked: no net buying on the exchange by an individual insider in the last 180 days.
Insiders' buying price vs the latest close
Insiders paid 2,705.18 KRW a share on average (1 purchase line, 1 buyer, 2026-03-24 – 2026-03-24). The close on 2026-10-16 was 31.2% below that price.
Prices paid are weighted by shares and taken from the filings; dividends are not counted. Not scored.
Insider trades on the exchange
Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.
| Trade date | Insider | Role | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-03-24 | Bonghwan Shin | CEO | Bought on the exchange | 8,291 | ₩2,705 | ₩22.4M | DART ↗ |